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Abstract  
Background: Antiretroviral therapy (ART) has the potential to significantly reduce the risk of HIV transmission 
and the spread of tuberculosis and improve quality of life. Patient’s adherence is crucial to get the best out of ART. 
As ART is scaled up in Ethiopia, there is a need for better understanding of the factors that influence patients’ 
adherence to ART and improve the service. This study aims to explore patients’ and health care professionals’ views 
about factors that facilitate and hinder adherence to ART among adult HIV patients.  
Methods: A qualitative grounded theory study using non-participant observation; and in-depth interview with 23 
ART users and 5 health professionals were carried out at two health facilities that serve a large number of 
HIVpositive individuals in Hawassa town, Southern Ethiopia. The study was conducted from February to April 
2014. Simultaneous data collection and analysis was conducted and taped Notes were transcribed into Amharic then 
translated into English. The grounded theory approach was used for analyzing the data. The analysis began by using 
the constant comparison approach. The coding process was preceded by open coding, axial and selective coding. To 
manage the overall coding process, Atlas.ti (v.7) software was used.   
Results: The commonest barriers to adherence-included poverty, substance misuse, forgetfulness and being busy, 
fear of stigma and discrimination, pill burden and medication side effects. The most frequently emerged facilitators 
to adherence included disclosure of HIV status, using an adherence aid, prospects of living longer, social support, 
experiencing better health and trusting health workers.   
Conclusion: The study revealed a range of barriers to adherence including individual, medical, environmental and 
economic related factors. The findings from our study can be used to inform the development of effective 
interventions that address the barriers and facilitators of ART adherence in Ethiopia. Priority should be given to 
improving adherence by alleviating financial constraints to ART adherence, better access to treatment services, 
education and counseling to tackle culture related obstacles, stigma and discrimination. [Ethiop. J. Health Dev.  
2016;30(2):66-77]  
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Background with agreed recommendations from a health care  
The emergence of the human immunodeficiency virus provider” (6). Studies have indicated that at least 95% (HIV) 
epidemic is one of the biggest public health adherence to ART drug regimen is optimal, but challenges the world 
has ever seen in recent history (1, adherence to treatment differs from compliance, which 2). In 2012, an estimated 
35.3million people globally only refers to a client’s behavior that conforms to were living with HIV (3). The 2012 
UNAIDS Global medical orders (7, 8). Non-adherence to ART refers to report stated that the number of people 
dying from failing to take the medication correctly, taking it AIDS-related causes began to decline in the mid-2000s 
inconsistently or in missing doses, factors which lead because of scaled-up antiretroviral therapy and the to increases 
in the frequency of opportunistic steady decline in HIV incidence since the peak in 1997 infections, faster 
progression of the disease and a (3, 4). The report also indicated that 9.7 million people substantial decline in health 
for HIV positive in low- and middle-income countries were receiving individuals (9). Non-adherence also reduces 
viral antiretroviral therapy in 2012, an increase of 1.6 suppression, causing an increase in the risk of the viral million 
over 2011(3). Declines in the annual number of strain quickly becoming drug resistant. Studies have AIDS-related 
deaths illustrate the powerful health found a strong statistical relationship between the benefits of scaled-up 
antiretroviral therapy (ART). failure to obtain scheduled pharmacy refills and a more ART not only prevents AIDS-
related illness and death, rapid progression to AIDS (10, 11).In this case, it also has the potential significantly reduce 
the risk of treatment options become fewer as resistance to one HIV transmission and the spread of an opportunistic 
drug will sometimes lead to resistance to other similar infection – tuberculosis (5). drugs in the same group leading 
to cross-resistance (9).  
8 School of Public Health, College of Medicine and Health Science, Bahir Dar University, Ethiopia;  
9 Department of Health Education and Behavioral sciences, Jimma University, Ethiopia;  
10 Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Maryland, USA 
4Department of Epidemiology and Biostatistics, College of Medicine and Health Sciences, Arba Minch University, 
Arba Minch, Ethiopia;   
11 School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.  
 
                                                          
68     Ethiop. J. Health Dev.  
  
    
Adherence is defined by WHO as “the extent to which A qualitative study in Addis Ababa hospitals on a person’s 
behavior- taking medication, following a pediatric patients reported several challenges to adhere diet, and or 
executing lifestyle changes, corresponds for ART such as pill burden, stigma and discrimination  
  
and awareness, access and economic problems (12). 
Similarly, a systematic review showed that behavioral 
interventions, directly observed therapy and adherence 
reminders were found to be important interventions to 
improve adherence for ART (13).  
  
According to the UNAIDS report, adult (15-49) HIV 
prevalence in Ethiopia is estimated 1.3% in 2012. 
Evidence shows that recent infection has decreased in 
the country and prevalence among young people has 
shown a remarkable decline over the last six years. 
Currently, an estimated number of 760,000 people live 
with HIV. Moreover, the estimated number of people 
needing ART stands at 400,000 for adults and 
approximately 14% of adults that are eligible for ART 
are not receiving ART (3, 14).  
  
Since 2003, the Government of Ethiopia has launched 
and implemented an ART program through the federal 
health sector with the goal of improving the quality of 
life of HIV positive individuals (2). However, recent 
studies conducted in Ethiopia suggest that adherence is 
not optimal, with a rate of 88.1% (15), suggesting that 
the emergence of drug resistant strains of HIV is a real 
threat (16).  
  
To date, there have been numerous studies in Ethiopia 
investigating and describing adherence rate.  
However, there is a lack of understanding regarding the 
barriers and facilitators to optimal ART adherence, and 
qualitative research may be best suited to explore these 
factors. Qualitative research is able to generate 
information from the respondent’s perspective in order 
to develop culturally appropriate and effective 
interventions, which are, in turn, more likely to lead to 
successful and sustainable programs (17). The scope of 
this study was to examine and conceptualize barriers and 
facilitators to adherence among people undergoing ART 
through key informant interviews in Hawassa town, 
Ethiopia. We interviewed both patients and health 
professionals with the intent of using the findings to 
improve treatment programs of clients with HIV/AIDS. 
To the best of our knowledge, no reports of previous 
qualitative adult ART adherence studies in Hawassa 
have been published.  
  
Methods   
Approach:  In this study, a grounded theory study design 
was used. This approach is well suited to study human 
experiences by considering cultural diversity of the 
participant under study. It is relevant to generate 
concepts, model or a substantive theory, which is 
complete, coherent and sheds light on the area under 
study rather than testing hypotheses based on existing 
theory. Despite the fact that events are processed and 
interpreted through the eyes of both participant and 
researcher, the grounding of theory in data tend to make 
the data more reflective of practical situations than 
speculatively derived theory (18).  
  
Setting:  We conducted the study in health facilities 
providing ART services at one public hospital (Adare 
Hospital) and one health center (Hawassa Millennium 
Health center) in Hawassa town. It is located about 275 
kilometers south of the nation’s capital and lies on the 
main road joining Ethiopia to Kenya. These two health 
facilities were chosen because they had already been 
providing ART for at least one year and had observed an 
increase in the number of ART users, relative to other 
health facilities in the region. The hospital launched its 
ART programme in 2006, while the health center started 
the programme in early 2012.  At  the  time  of  the  study,  
Adare Hospital  had  a  total of  982  registered  ART 
users and Hawassa Millennium Health center had  a  total 
of  91 registered ART  users.  
The study was carried out from February to April 2014.  
  
Study participants:  We recruited a total of 28 
informants from the two institutions; adult ART- 
prescribed patients and key informants, such as health 
professionals, who are involved in the process of ART 
counseling and care-giving. ART- prescribed patient’s 
participants were eligible for the study if they were at 
least 18 years old, had been receiving ART in the study 
clinic for at least a month, and who provided study 
consent, and health professionals were eligible if they 
provided study consent. We chose to interview 
individuals from both groups for a number of reasons. 
ART-prescribed patients were chosen to better 
understand barriers and facilitators from the patient 
perspective.  
  
Health professionals were chosen because of their 
involvement in counseling and treating people living 
with HIV and to provide a health care provider 
perspective. Purposive sampling and theoretical 
sampling strategies were used to recruit the participants. 
Purposive sampling was made to seek participants with 
a variety of ages, gender, duration of ART use and 
educational status as the study progressed in an attempt 
to obtain diverse perspectives. Intensity and criterion 
based purposive sampling was used to identify common 
themes that transcend a focused sample. Theoretical 
sampling was also used to provide further insights on the 
evolving understanding obtained during data analysis. 
Health professionals were identified with the assistance 
of the health facilities manager or senior health worker 
at the clinic. Initially, we interviewed health care 
providers to have an indepth understanding of various 
concepts related to the study objectives.  
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Health professionals aware of patients’ treatment 
histories, supplemented by checking of patients’ medical 
records, helped to identify and recruit relevant adherent 
and non-adherent participants into the study. The 
selection process was simultaneous which is 
characterized by analyzing the data after the first data 
was gathered and then emerging concepts/categories 
were included which in turn leads to more data collection 
to understand the concepts/categories generated deeply. 
This process of data collection continued until it reached 
to the point of saturation (19). In this study, data 
saturation was obtained after 19 interviews; the final four 
interviews did not present any new information, rather 
they strengthened the core category of the theory.  
  
Data collection and analysis:  The data were collected 
using non-participant observation and semi structured 
in-depth interviews by the lead author. After giving 
consent, all interviews were conducted in Amharic 
language with each informant in a private room at the 
clinic. Each session lasted between 45 and 90 minutes.  
  
The lead author concurrently gathered, managed and 
interpreted the data, and a grounded theory methodology 
was used. Data were analyzed as interviews were 
completed to identify emerging concepts and categories, 
and we sought to more deeply understand initial concept 
and categories in subsequent interviews. This process of 
data collection continued until it reached to the point of 
saturation (19). Accurate transcribing of audiotaped 
interviews were done and digital audio recordings of the 
interviews were transcribed verbatim in English by the 
lead author. The data was entered and analyzed using 
Atlas.ti (v.7) software, which helped to structure and 
manage the overall coding and analysis process.  
  
The data analysis process was undertaken in three stages:  
open/initial, selective, and theoretical coding. In the 
open/initial coding process, the transcripts were 
inductively analyzed line by line, and several codes were 
developed to assess the data. Subsequently, the open 
codes were clustered into categories.  
  
The lead author led the analysis for each transcript, until 
the core category emerged. Once the core category was 
generated, the sampling became selective, and sub-
categories and their properties were developed using 
further data collection and a constant comparison of the 
data as a whole. In the theoretical phase of the analysis, 
the relationships between the core category and its sub-
categories were determined and described. The 
processes were continued until no new properties 
emerged and theoretical saturation was reached. In 
accordance with the grounded theory method, memos 
were also written during the entire analytical process to 
record ideas about emerging categories and assumptions 
about their relationships (18). 
Rigor and Trustworthiness of the study:  Data were 
collected from different participants’ perspective 
(subjected to triangulation). We also invited some 
participants once the data was analyzed to review the 
findings and ideas, which they think the investigator had 
presented a true picture from their perspective. In 
addition, the investigators developed an early familiarity 
with the culture of the selected health facilities in order 
to gain an adequate understanding of the organization 
and to establish a relationship of trust.  
  
An audit trial was created throughout the data collection. 
Moreover, debriefing sessions with public health 
postgraduate students from different backgrounds were 
used to check the consistency between the analyzed data 
and the theory developed.  
  
Rigor is attained through strict attention to detail, 
adhering to procedures and through consistency and 
accuracy throughout the research process (20), each of 
which the investigators was considered at all times. In 
this research, we did an explorative study and explained 
the core phenomena well. Moreover, at the end we left 
open the stage on the proposed theoretical explanation 
for further modification of the model.  
  
Ethical issues:  Ethical approval for the study was 
obtained from Ethical Review Committee of the College 
of Health Sciences, Jimma University. Permission was 
obtained from the facilities and verbal consent was 
obtained from all informants. The informed consent and 
interview procedures were conducted completely in a 
private setting or room. The informants were ensured 
that all data would be kept confidential by using codes to 
identify participants instead of names, medical record 
numbers, or any other personal identifiers. Informants 
were also clearly informed about their right to refuse to 
participate in the study or withdraw at any time during 
the interview session. Completed written and recorded 
information were kept in a secured place.   
  
Results  
Characteristics of the participants:  A total of 23 
patients on ART and 5 health providers participated in 
the study. Majority of the patients were female, at 
primary level of education, less than three years since 
they knew their HIV status and took ART less than a year 
(Table 1 and 2).  
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Table 1: Characteristics of ART- prescribed patients involved in in-depth Interview 
from health setup in Hawassa, February - April 2014 (N=23)  
Characteristics of participants  Frequency  
  
  
Table 2: Health professionals involved in in-depth interview from health setup in Hawassa, February - April 
2014 (N=5)  
Profession   Age in  Level of education  Position   Experience with ART (year)   
years    
  
Thematic areas:  The study identified several perceived 
barriers and facilitators to patient adherence to ART. The 
categories that emerged were classified into four themes: 
(I) individual patients’ beliefs and behaviors related 
themes; (II) socioeconomic and cultural related themes; 
(III) healthcare provision and system related themes; 
(IV) drug related themes on barriers and facilitators of 
ART adherence.  
  




Feeling better (drug holiday), substance-misuse (alcohol 
use), perception about ART, simply forgetting and being 
busy and having responsibilities of family work were 
reported as barriers to adherence.  
  
Feeling better (drug holiday) Patients and 
health professionals both mentioned that some patients 
would skip their dose when 
they were feeling better or 
their CD4 test result 
improved.  
  
“There is this patient in my 
neighborhood. She has stopped taking her medication 
after feeling well. She said that the drugs are too many 
to be taken every day in the morning and evening as if 
it is a rayer.”(Female patient, 34 years)I  
    
A 25 year-old female clinical nurse also agreed that lack 
of self-motivation to take the drug due to feeling better 
continuously results in low adherence. She said:  “Some 
patients, after taking the ART drug for 6 to 12 months, 
their CD4 count improve and their health status get 
better and have no symptoms, they (ART users) assume 
as if they are cured and then they stop taking ART”  
  
Substance-misuse   
Both health professionals and patients as why some 
patients were not adhering to their ART medications 
mentioned misuse of substance, especially alcohol use.   
    
“I used to drink alcohol until 9 to 10 pm, this condition 
seriously affected the schedule of my pills; hence forth, I 
was taking the pills irregularly. However currently I 
stopped taking alcohol and become very strict in taking  
Gender    
   Male  10  
   Female  13  
Age in years    
   35 years and below  15  
   Above 35 years old  8  
Educational level    
   Illiterate  3  
   Primary education (1-8 grade)  13  
   Secondary education (9-12)  6  
   Tertiary and above (college and above)  1  
Duration since knowing HIV test result    
   Less than 3 years  14  
   Above 3 years  9  
Length of time on ART treatment    
   Taking ART <12 months  12  
   Taking ART > 12 months  11  
Health officer   38  Bsc  ART clinic focal person  3   
Health officer  46   Bsc  ART clinic focal person  4   
Clinical nurse   25   Diploma   ART nurse   3   
Laboratory technician  29  Diploma   Adherence supporter  3   
-  33  Certificates   Case manager   6    
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my pills on time every day.”(Male, patient, 35 years)  
  
Simply forgetting and being busy  
Both patients and health professionals reported that most 
patients forgot their medication due to daily routine 
activities, being busy and away from home, and having 
responsibilities of family work and social events like 
wedding and mourning events.  
  
“Unless I forgot my medication at home due to certain 
occasions, there is nothing that can prevent me from 
taking my medication. Yes, let me tell you what I faced 
once. I remembered, there was my friend’s wedding and 
I was with my friends, that day I forget taking my 
medication with me and that was the only moment I have 
never taken medication in my life”. (Male, patient, 30 
years)  
  
Having responsibilities of family work  
A 30 years old female ART user also is closed of simply 
forgetting due to having responsibilities of the family.  
   
“...I remember I interrupted to take my pills for 3 days, 
it is because of my daughter having developed severe 
pain so at that time I should do everything to save my 




Adherence aids, responsibilities related to family, 
experiencing better health, and prospects of living 
longer, and disclosure of HIV status were perceived as 
facilitators to ART adherence. Both patients and health 
professionals most frequently mentioned setting alarms 
on watches and mobile phones as a way to cope with 
their medication in different situations. In addition, ART 
patients also used TV or radio programs to remind them 
to take their pills.  A mobile phone alarm is the most 
common adherence aid that many ART users often use 
to take their medications.   
  
“I always set an alarm on my mobile phone to take my 
pills on time and it helps me to remember the time of my 
medication even when I am busy ....” (Male, patient, 29 
years)  
  
Both health professionals and several ART users that 
caring for family and having responsibility for looking 
after children was one of the most frequently mentioned 
facilitators of adherence also mentioned it.   
  
“...for example, when I see my daughter I weep internally 
all the time because I always dream the best future life 
for her and I am responsible. By taking my drugs 
regularly and on time I don’t hesitate looking  
her until my death...” (Male, patient, 57 years)  
  
Socio-economic and cultural related themes  
HIV is still a sensitive social, economical and cultural 
issue in Ethiopia, and the findings of this study supported 
this by identifying the barriers and facilitators below.  
  
Barriers  
Economic constraints, stigma and discrimination, 
barriers relating to religion and rituals, lack of 
emotional/psychological support and social events were 
reported as barriers to adherence.   
  
Economic constraints  
Participants in this study reported that economic worries 
related to unemployment, food insecurity, charges for 
diagnosis and treatment and cost of transport problems 
were some of the economic-related difficulties they 
experienced in trying to adhere to the treatment regimen.  
  
Individuals who were unemployed  had difficulties in 
meeting their food needs and in facing challenges of 
getting to and from health care facilities which are often 
not in the immediate vicinity. The following quote from 
68 year old unemployed male patient highlight the 
challenges he faced due to unemployment and not 
having money:   
  
“…because I am in a serious economic problem and 
nobody supports me, I am not getting my daily breakfast, 
lunch and dinner properly. If I had money, I would buy 
vegetables, fruits any other important food item, which 
increases my immunity against the disease and my body 
weight too. So being under poor  
economic condition is my major problem…..’’  
  
Similarly, 36 years old ART clinic health professional 
also spoke of the link between money and adherence:  
“.......... sometimes they do not have food at all at home, 
so they do not take their drugs (ART) because they get 
hungry”   
  
Stigma and discrimination  
Despite the positive benefits of ART, throughout the 
interviews, both ART-prescribed patients and health 
professionals mentioned that most ART users were more 
likely to disclose their HIV status to people they live 
with, and were less likely to tell others, even their very 
close relatives such as parents, brothers, and sisters. 
Many of them reported that stigma and discrimination 
related to being HIV positive were still present in their 
communities and have a strong influence on how 
patients adherence, leading to patients hiding pills, 
occasional skipping of medications and failing to keep 
clinic appointments for drug refills or examinations.  
  
A 35-year-old female described her fear of self and 
discrimination of her family by community members:    
“Other than my children, no one knows whether I am 
taking this medication or not and also I don’t want 
others to know. I would like to go out confidential; 
without anyone staring and talking at me and my 
children’s because our place is a talkative place which  
prevents our free movement in and out from home...”  
  
Barriers relating to religion and rituals  
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People are pressured to be abided by their community’s 
local and traditional religious and cultural rituals, which 
can influence adherence to ART. Religious rituals like 
fasting and holy water were found to influence 
medication adherence.   
  
“I don’t take my drugs when I visit church for holy water 
and the like because I do not want to be seen by anyone 
because it is not allowed not only to take drug but also 
to drink water in the church. Due to this reason, 
sometimes I postpone the time of taking my pills”. (Male, 




Disclosure of HIV status, programs for income 
generation, and looking someone improved with ART 
were reported as facilitators of adherence. Despite being 
regarded by many as an important barrier to adherence, 
some informants identified self-disclosure of HIV status 
as a critical facilitator of ART adherence, usually linked 
to the support by ART users received from partners, 
children, parents, peers, and self-help groups. Most of 
the ART users reported that their children play critical 
and active role in reminding and encouraging taking 
their pills.  
  
“The drug schedule does not take my time because I take 
the drugs at night time. I take the drug exactly at 9 pm. 
If I forget to take the drug   at 9 pm, my children remind 
me. I take   bacterium tablets after lunch at 2pm.At all 
times my children help me through remembering the time 
to take the drug. They woke me up from bed so that I 
should not miss the right time. Hence, I am taking the 
drug seriously as it is for my survival and also so that my 
children don’t miss a parent since their father has died.” 
(Female, patient,  
28 years)  
  
Healthcare provision and system related themes 
Informants pointed to healthcare provision and issues 




Poor clinic infrastructure and perceived stigma, fatigue 
of healthcare providers, long waiting times, and charges 
for diagnosis were all reported as barriers to adherence.  
  
Poor clinic infrastructure and perceive stigma  
Poor hospital ART clinic location and setup, such as 
clinics being located in front of the cafeteria, the 
unsatisfactory conditions of the ART room for 
counseling, and keeping patient confidentiality during 
clinical visits were perceived as major barriers to 
adherence. For example, examining patients, data clerk 
activity, counseling and consultations often took place in 
the same and open rooms in the presence of other 
patients and different health professionals. Many 
therefore found it difficult to speak openly, as they were 
worried that peers would judge or expose their current 
condition.   
  
Long waiting time at facility (card room)  
The time that the patients spends at the health care 
facility often leads to frustration and places an additional 
burden on those who have not disclosed their status to 
others.   
  
Charges for diagnosis  
All patients and health professionals involved in this 
study reported that all of the patients enrolled in the ART 
clinic receive their ARTs and some laboratory diagnoses 
(CD4 & CBC) free of charge, and were considered 
facilitators of ART adherence. However, the additional 
ART related cost that a patient had to pay was described 
as a constraint to adherence and a major reason why 
some individuals do not come to the health facilities to 
fill their prescription, even when the treatment itself is 
free of charge, especially for many ART users who were 
poor, and unemployed.  
   
 “... The other problem that occurs at this area is that 
patients need to bear the treatment for most of 
opportunistic infection treatments and diagnostic 
(laboratory) costs except for CBC and CD4 even if most 
of the patients have the problem of money.”  
(Female, ART clinic focal person, 46 years)  
  
Facilitators  
Nutritional support, counseling and education, trusting 
health workers, and government policy of free ART 
treatment were mentioned as important for improving 
adherence. Both patients and health professionals 
mentioned the Food by Prescription (FBP) nutritional 
support as another key facilitator.  
  
Most patients said that education and counseling they 
received about ART in the ART clinics, from an 
adherent supporter and case manager, motivated them to 
take the medication. From the observational finding and 
interview of patients reports suggest that adherence 
supporter, case managers and health care professional 
provided education, which focused on the importance of 
adherence, strategies to improve adherence, 
consequences of non-adherence, possible side effects of 
the medications, and the duration of treatment required 
in a comfortable manner for a patients.  
  
“Since our government provides us the drug for free, we 
have no more cost other than some transport cost. This 
encourages us to take the drug consistently. We should 
not need to have an appointment or some other  
advice to take the drugs.” (Male, patient, 35 years)  
  
Drug related theme  
Pill burden and side effects of the drug were the major 
reasons for patients to be non-adherent; while the 
consistent and contrasting themes experiencing 
selfimprovement of health-facilitated adherence  
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Barriers    
Pill burden (duration of the treatment, frequency of 
dosing), size of the drugs and side effects of the drugs 
were reported as barriers to adherence.  
  
Most ART-prescribed patients mentioned pill burden as 
a major challenge of adhering to treatment and in 
addition to ART drugs, some patients were also taking 
tuberculosis drugs and co-trimoxazole for PCP 
prophylaxis as well as other drugs for other illnesses. 
Side effects were experienced by almost all of the 
participants, primarily when initiating ART treatment 
or upon initiation of concomitant treatment. Among 
side effects, patients mentioned were blurred vision, 
itching of the skin, generalized body weakness, body 
shape disturbance, poor appetite, nausea, burning of the 
stomach, headache, bad dreams, rash and vomiting. 
The following response from 57-year-old married man 
indicated the overall difficulties that ART users face 
including pill burden, side effects of the drugs, and the 
size of the drugs:  
  
“…… for me as you see “it creates depressions over the 
face”, for others too “it changes the shape of the users 
that is fat body above and thin body below the loin 
forming two different shapes within an 
individual..”……………moreover, related to the size of 
the drug, you see this drug which I took it now is too 
large which fills mouth &even difficult to pass through 
esophagus unless you take it with adequate water. This 
is one of the reasons why we can’t able to go anywhere 
by having it much drug at a time”.   
  
Facilitators  
Experience of direct observation of improved health 
among ART users, experiencing self- improvement of 
health on ART and having a simple regimen were 
frequently reported as important for improving 
adherence. Most ART users were very optimistic about 
ART efficacy, fear of negative consequences of 
nonadherence, experiencing improved health while on 
ART, and observation of improved health among other 
ART patients as motivators for adherence. Both patients 
and health professionals reported ART increased body-
weight and appetite, reduced opportunistic infections, 
and improved quality of life. “............ taking the 
medications have helped us a lot even it increase our 
CD4, for example I can see for myself: when I started the 
treatment my CD4 was 246 but after I took the treatment 
for 3 month my CD4 increased around 400 and not only 
that but also I am not exposed for any disease still now, 
so this one is also best evidence about the effectiveness 
of the drugs.  I believe that the treatment helps because 
in some way  
I am seeing the results.” (Male, patient, 35 years)  
  
A 25 years old female clinical nurse also said:   “......... 
yes for example most of our patient were coming after 
they develop opportunistic infections(OIs) because most 
of the patient check their HIV status after they observe 
and develop some sign and symptoms of the disease there 
are only some patients who are coming to check their 
results voluntarily. After they take the drugs, they see 
improvement of health after treatment of OIs and 
progressive increments of CD4 counts which makes 
them to develop trust on the drugs and adhere well”.   
  
Furthermore, both patients and health professionals 
explained that the fear of returning to a poor physical 
state or, even worse, death, strongly motivated them to 
adherence.  
  
Finally, a framework was developed based on the 
analysis procedures of the study as presented in the 
following figure (Figure 1).   
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Discussion    
The study identified barriers and facilitators, which were 
diverse in nature, with a wide spectrum of factors related 
to individual patients’ beliefs and behaviors attributed to 
socioeconomic and cultural, the health services and 
treatment related issues. We identified that using an 
adherence aid, prospects of living longer, disclosure of 
HIV status, social support, experiencing better health 
and trusting health workers were the most frequently 
cited facilitators. In addition, economic constraints, 
substance misuse, simply forgetting and being busy, fear 
of stigma and discrimination, pill burden and medication 
side effects were the most frequent cited barriers. The 
study results are similar to other qualitative studies in 
developing countries (21) and findings reported in other 
regions of Ethiopia (2224) and elsewhere in resource-
limited settings (25-27).   
  
The major individual patients’ beliefs and behaviors 
constraints that negatively affected adherence were 
substance misuse, especially alcohol use. Both patients 
and health professionals mentioned a direct link between 
alcohol abuse and non-adherence because alcohol 
drinkers often “ignore” or “forget” their medications. 
Some patients also believed that drinking alcohol and 
taking ART together was harmful, and decided to “skip 
the pills”. Results of this study revealed that alcohol use 
Figure 1.   Theoretical framework of Barriers and Facilitators to AR T adherence developed from the study   
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increased non-adherence, and similar findings have been 
reported elsewhere (26, 28, 29), while one study showed 
that not using substances increased adherence (30).  
  
Socio-economic constraints, such as unemployment and 
food insecurity, were major limitations that negatively 
affected medication adherence and remaining in care. 
Although ART is free in a number of countries in the 
region, treatment-related expenses still hinder patients’ 
access to treatment (31, 32). The findings of this study 
are in concordance with those from other studies, which 
have found that lack of food due to economic constraints 
is a common obstacle to patients taking their treatment 
(33-35). Lack of food was mentioned by both patients 
and health professionals as a cause of non-adherence, 
and has been identified in other studies as a factor 
responsible for treatment default (36, 37).  
  
Socio-cultural factors, such as stigma and discrimination 
and religious rituals, also had undesirable effects on 
medication adherence and remaining in care. Informants 
articulated that stigma and discrimination was still 
widespread, from families of patients as well as 
communities. Some participants did not take medicine in 
front of people they knew due to fear of being identified 
as HIV-positive, similar to other studies (38), while other 
studies conclude that patients seek treatment at health 
facilities far away from home to hide their HIV status 
(39). Interventions targeting communities to improve 
social awareness in the public including information 
provision, skill building, counseling and facilitating 
interaction between people with HIV/AIDS and the 
community, have the potential to reduce stigma and 
improve ART adherence (40, 41).  
  
Other barriers to adherence included local cultural 
factors, especially religious activities; patients miss or 
delay medications to fulfill religious obligations. One 
study conducted in Ethiopia also found that seeking 
traditional treatment to be the most important reason for 
patients being lost to follow-up care (42). The findings 
of this study reinforce the importance of considering 
religious and spiritual beliefs of HIV positive individuals 
as part of medical care.  
  
This study revealed that poor clinical infrastructure with 
insufficient facilities for conducting confidential 
consultations prevented patients from communicating 
openly with health care providers. Insufficient 
counseling could facilitate misunderstandings about 
taking ART, leading to lower adherence. Confidentiality 
at treatment centers, particularly at card rooms, was 
another issue that emerged from the study. Studies from 
Botswana and Senegal have suggested that HIV patients 
tended to reduce clinical visits because of the risk of 
being seen by others and potentially having their HIV 
status exposed (43, 44). This illustrates the importance 
of bearing in mind confidentiality and issues of stigma 
and creating infrastructure that is more agreeable to 
patient confidentiality, which is an imperative 
consideration when the provision of ART is being scaled 
up.  
  
Medication side effect symptoms are frequent in people 
treated with ART and are of the most important 
biological elements associated with non-adherence (45, 
46). Almost all of the informants reported that side 
effects contributed in a significant way as to how they 
managed their regimen. ART medication is associated 
with adverse side effects ranging from mild to severe, 
and it is crucial for medical practitioners to manage these 
symptoms (46, 47). However, as it has been seen in the 
discussion on the complexity of treatment, taking extra 
medication to counter the side effects may add to the pill 
burden for the HIV positive individuals. This is 
supported by research where it was found that those who 
were put on mono-therapy instead of dual or triple 
therapy showed better adherence outcomes (47).  
  
In Hawassa, HIV positive individuals may be in 
particular need of ART adherence interventions that 
address strategies to improve adherence through the 
patient-provider relationship and improved strategies to 
incorporate ART pill taking regimens into a busy urban 
lifestyle where individuals may feel stigmatized by their 
HIV positive status. One effective strategy that may 
address these factors in an environment such as 
Hawassa, Ethiopia may involve the use of electronic 
devices, like mobile phones and alarms. Mobile phones 
have been successfully used to support patient 
medication adherence in developed countries (48) and in 
resource-constrained settings such as Uganda (49), 
Kenya (50, 51) and South Africa (52). Mobile phones 
might be an ideal tool to improve ART adherences for 
HIV patients in Hawassa because they can be private, 
interactive, efficient, affordable, convenient, and useful 
as a reminder tool.  
  
A remarkable finding in this study was that patients’ 
feeling of improved health and disclosure of HIV status 
could be a barrier as well as a facilitator to adherence. 
Patients and health professionals mentioned that patients 
were motivated to continue taking their medications 
when they began to feel better after initiating ART. On 
the other hand, some patients discontinued taking their 
medication when they felt better. Improvement of 
subjective health has to be understood in the context of 
patients’ beliefs about the treatment, as some patients 
believed they were healed and therefore did not 
understand why they should continue taking their 
medication. Earlier studies also reported that feeling 
better could act as a barrier or as a facilitator to 
adherence (53). Adherence counseling is commonly 
offered to patients at the start of ART; however, these 
findings indicated that the stage of treatment when 
patients are starting to feel better could be a critical 
turning point with regard to adherence. Thus, counseling 
activities that specifically target patients during this 
treatment phase may be worth considering.  
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The finding of this study is based on interviews with 28 
informants, and is limited to one geographical area. The 
results of this study reflect diversity in views and 
experiences; we also triangulated data sources and 
subject in order to strengthen the validity of our results, 
although we are unable to determine to what extent 
different factors are important barriers or facilitators in 
other contexts. Another limitation of this study is that the 
research did not include patients who did not seek help 
at the clinics. Despite these limitations, these findings 
offer an understanding of the complexity and dynamics 




The study revealed a range of barriers to adherence: 
economic constraints, substance misuse, simply 
forgetting and being busy, fear of stigma and 
discrimination, pill burden and medication side effects. 
Experiencing better health, adherence aid, prospects of 
living longer, disclosure of HIV status, social support, 
and trusting health workers were the most common 
reported facilitators. The findings of this study can be 
used to inform the development of effective 
interventions that address the barriers and facilitators of 
ART adherence in Ethiopia. Priority should be given to 
improving adherence by alleviating financial constraints 
to ART adherence, better access to treatment services, 
education and counseling to manage religious and ritual 
obstacles, stigma and discrimination. In addition, health 
professionals should explain side effects of drugs and 
how to manage them. Reshuffling the rooms to make the 
ART room more private, devise mechanisms by the 
service providers and develop mechanisms to shorten 
long waiting hours. The role of Health Extension 
Workers related to ART adherence and quality of health 
service on adherence can be further area of investigation.  
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